Tellus Therapeutics Revenue and Competitors

Hillsborough, NC

Location

$2.4M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Tellus Therapeutics's estimated annual revenue is currently $852.5k per year.(i)
  • Tellus Therapeutics's estimated revenue per employee is $77,500
  • Tellus Therapeutics's total funding is $2.4M.

Employee Data

  • Tellus Therapeutics has 11 Employees.(i)
  • Tellus Therapeutics grew their employee count by 10% last year.

Tellus Therapeutics's People

NameTitleEmail/Phone
1
Co-founder and CEOReveal Email/Phone
2
VP Operations and FinanceReveal Email/Phone
3
VP Clinical Operations and Business DevelopmentReveal Email/Phone
4
Co-Founder, Chief Scientific OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11.2M72-13%N/AN/A
#2
$5099.8M32902-4%N/AN/A
#3
$1.7M110%N/AN/A
#4
$0.6M4-56%N/AN/A
#5
$0.9M11-39%N/AN/A
#6
$1.7M1110%N/AN/A
#7
$0.6M4-33%N/AN/A
#8
$4.8M31-6%N/AN/A
#9
$6.4M413%N/AN/A
#10
$4.2M27-18%N/AN/A
Add Company

What Is Tellus Therapeutics?

Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. Tellus' lead candidate, TT-20, induces regeneration of myelin-producing oligodendrocytes, reverses white matter injury in an animal models of perinatal brain injury and multiple sclerosis and is pursuing a novel regulatory path to evaluate safety and efficacy in newborns with brain injury.

keywords:N/A

$2.4M

Total Funding

11

Number of Employees

$852.5k

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Tellus Therapeutics News

2022-03-30 - Triangle Inno - Triangle Inno Madness winner crowned

Tellus Therapeutics: Tellus Therapeutics is using technology licensed from Duke University to develop a treatment for babies born at risk of...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M110%N/A
#2
$1M1110%N/A
#3
$1M11-27%N/A
#4
$1.6M18-5%N/A
#5
$3.1M190%N/A